Involvement of the carboxyl terminus of the third intracellular loop of the cannabinoid CB1 receptor in constitutive activation of G(s)

Journal of Neurochemistry

Volumn 72, Issue 5, 1999, Pages 2032-2038

  Abadji, Vasiliki ^a   Lucas Lenard, Jean M ^a   Chin, Chen Ni ^a   Kendall, Debra A ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Adenylyl cyclase; Cannabinoid receptor; Cyclic AMP; G protein coupled receptor; G(i); G(s)

Indexed keywords

4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID RECEPTOR; CHOLERA TOXIN; CYCLIC AMP; PERTUSSIS TOXIN; RIMONABANT;

ANIMAL CELL; ARTICLE; CANNABIS ADDICTION; CARBOXY TERMINAL SEQUENCE; CHO CELL; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; INTRACELLULAR TRANSPORT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING; RECEPTOR UPREGULATION;

ANIMALS; CHO CELLS; CHOLERA TOXIN; CRICETINAE; CYCLIC AMP; CYCLOHEXANOLS; GTP-BINDING PROTEINS; HUMANS; MUTATION; PEPTIDE FRAGMENTS; PERTUSSIS TOXIN; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; VIRULENCE FACTORS, BORDETELLA;

ANIMALIA; CANNABIS;

EID: 0033048373     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0722032.x     Document Type: Article

References (34)

1. Abadji V., Lin S., Taha G., Griffin G., Stevenson L. A., Pertwee R. G., and Makriyannis A. (1994) (R)-Methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J. Med. Chem. 37, 1889-1893.
2. Abood M. E., Ditto K. E., Noel M. A., Showalter V. M., and Tao Q. (1997) Isolation and expression of a mouse CB1 cannabinoid receptor gene. Biochem. Pharmacol. 53, 207-214.
3. q/11. J. Biol. Chem. 269, 13733-13735.
4. Bouaboula M., Perrachon S., Milligan L., Canat X., Rinaldi-Carmona M., Portier M., Barth F., Calandra B., Pecceu F., Lupker J., Maffrand J.-P., Le Fur G., and Casellas P. (1997) A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. J. Biol. Chem. 272, 22330-22339.
5. Bradford M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
6. Cassel D. and Selinger Z. (1977) Mechanism of adenylate cyclase activation by cholera toxin: inhibition of GTP hydrolysis at the regulatory site. Proc. Natl. Acad. Sci. USA 74, 3307-3311.
7. Chin C., Lucas-Lenard J., Abadji V., and Kendall D. A. (1998) Ligand binding and modulation of cyclic AMP levels depend on the chemical nature of residue 192 of the human cannabinoid receptor 1. J. Neurochem. 70, 366-373.
8. Cotecchia S., Exum S., Caron M. G., and Leflowitz R. J. (1990) Regions of the α1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc. Natl. Acad. Sci. USA 87, 2896-2900.
9. Deadwyler S. A., Hampson R. E., Bennett B. A., Edwards T. A., Mu J., Pacheco M. A., Ward S. J., and Childers S. R. (1993) Cannabinoids modulate potassium current in cultured hippocampal neurons. Receptors Channels 1, 121-134.
10. Eason M. G., Kurose H., Holt B. D., Raymond J. R., and Liggett S. B. (1992) Simultaneous coupling of α2-adrenergic receptors to two G-proteins with opposing effects. J. Biol. Chem. 267, 15795-15801.
11. s. Mol. Pharmacol. 45, 696-702.
12. i-protein βγ subunits. Nature 356, 159-161.
13. Felder C. C., Veluz J. S., Williams H. L., Briley E. M., and Matsuda L. A. (1992) Cannabinoid agonists stimulate both receptor-and non-receptor-mediated signal transduction pathways in cells transfected with and expressing cannabinoid receptor clones. Mol. Pharmacol. 42, 838-845.
14. Gerard C. M., Mollereau C., Vassart G., and Parmentier M. (1991) Molecular cloning of a human cannabinoid receptor which is also expressed in testis. Biochem. J. 279, 129-134.
15. s linkage to the CB1 receptor. J. Neurosci. 17, 5327-5333.
16. i proteins in dual coupling of the luteinizing hormone receptor to adenylyl cyclase and phospholipase C. J. Biol. Chem. 271, 16764-16772.
17. i in the inhibition of adenylate cyclase by cannabimimetic drugs. Mol. Pharmacol. 29, 307-313.
18. 1B-adrenergic receptor by all amino acid substitutions at a single site. J. Biol. Chem. 267, 1430-1433.
19. Leff P., Scarmellini C., Law C., and McKechnie K. (1997) A three-state receptor model of agonist action. Trends Pharmacol. Sci. 18, 355-362.
20. Lefkowitz R. J., Coctecchia S., Samama P., and Costa T. (1993) Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14, 303-307.
21. Mackie K. and Hille B. (1992) Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. USA 89, 3825-3829.
22. Matsuda L. A., Lolait S. J., Brownstein M. J., Young A. C., and Bonner T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346, 561-564.
23. Moss J., Bruni P., Hsia J. A., Watkin P. A., Halpern J. L., Burns D. L., Kanaho Y., Chang P. P., and Hewlett E. L. (1984) Pertussis toxin-catalyzed ADP ribosylation: effects on the coupling of inhibitory receptors to the adenylate cyclase system. J. Recept. Res. 4, 459-474.
24. Munro S., Thomas K. L., and Abu-Shaar M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
25. Padmanabhan S., Marqusee S., Ridgeway T., Laue T. M., and Baldwin R. L. (1990) Relative helix-forming tendencies of nonpolar amino acids. Nature 344, 268-270.
26. Perez D. M., Hwa J., Gaivin R., Mathur M., Brown F., and Graham R. M. (1996) Constitutive activation of a single effector pathway: evidence for multiple activation states of a G protein-coupled receptor. Mol. Pharmacol. 49, 112-122.
27. Ren Q., Kurose H., Lefkowitz R. J., and Cotecchia S. (1993) Constitutively active mutants of the alpha 2 adrenergic receptor. J. Biol. Chem. 268, 16483-16487.
28. Rinadi-Carmona M., Barth F., Heaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Neliat G., Caput D., Ferrara P., Soubrie P., Breliere J. C., and Le Fur G. (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett. 350, 240-244.
29. 2-adrenergic receptor. J. Biol. Chem. 268, 4625-4636.
30. Sanger F., Nicklen S., and Coulson A. R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74, 5463-5467.
31. 1B-adrenergic receptor: role of highly conserved polar amino acids in receptor activation. EMBO J. 15, 3566-3578.
32. sα activates adenylyl cyclase. Nat. Struct. Biol. 5, 88-92.
33. s with the cytosolic domains of mammalian adenylyl cyclase. J. Biol. Chem. 272, 22265-22271.
34. 2A-adrenergic receptors: identification of amino acids involved in ligand binding and receptor activation by agonists. Mol. Pharmacol. 40, 168-179.